Astec LifeSciences — 360° view

Astec LifeSciences, a company in the Pesticides & Agrochemicals industry, reported revenue of ₹72 crore and a net loss of ₹37 crore for the September 2026 quarter.

Astec LifeSciences (NSE: ASTEC) closed at ₹541.70 on 20 Nov 2026, down 26.2% over the past year. Its market capitalisation is ₹1,207 crore.

Share price
₹541.70 (20 Nov 2026)
Market cap
₹1,207 Cr (20 Nov 2026)
Revenue
₹72 Cr (September 2026 quarter)
Net profit
₹-37 Cr (September 2026 quarter)
ROCE
-5.44% (FY26)
ROE
-25.2% (FY26)
Book value
₹150 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹941.75 / ₹509.60 (20 Nov 2026)
1-year return
-26.2% (to 20 Nov 2026)
Sector
Commodities
Industry
Pesticides & Agrochemicals
Symbol
NSE: ASTEC

The Company is into manufacturing of agrochemical active ingredients (technical), bulk and formulations, intermediate products and it sells its products in India as well as exports them to approximately 24 countries. Astec also has undertaken a number of custom synthesis projects, for its clients in Europe, Japan and the US. It is present only in business to business sale (B2B).

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.